(Allergan plc)

	AGN latest price $154.4214 (0.32%) ($153.2277 - $155.8240) on Thu. Nov. 29, 2018.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.71% (three month average)
RSI	22
Latest Price	$154.4214(0.32%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.1% a day on average for past five trading days.
Weekly Trend	AGN declines -3% a week on average for past two weeks.
Market Behavior	Normal for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(50%)    ARKG(48%)    XBI(47%)    XLV(47%)    IWO(46%)
Factors Impacting AGN price	AGN will decline at least -0.855% in a week (0% probabilities).   VIXM(-26%)    TLT(-24%)    UUP(-19%)    DIA(-16%)    VXX(-15%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.855% (StdDev 1.71%)
Hourly BBV	0 ()
Intraday Trend	0.4%

1 - 5 Day Possible Target	$147.97(-4.18%)
Resistance Level	$158.46
5 Day Moving Average	$152.95(0.96%)
10 Day Moving Average	$154.03(0.25%)
20 Day Moving Average	$158.46(-2.55%)
To recent high	-19.4%
To recent low	2.1%
Market Cap	$50.913b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed